The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival
- PMID: 10310599
- PMCID: PMC4191361
The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival
Abstract
This article presents a detailed account of the incidence, prevalence, and survival experience of people with end-stage renal disease (ESRD) covered by Medicare. The number of new entrants into the ESRD program has risen since its inception. This increase is greatest for people whose cause of renal failure is primary hypertensive disease or diabetic nephropathy. The program incidence rates for black people is 2.8 times that of white people. Incidence is highest for persons 65 to 69 years of age. Total patient survival is 44 percent 5 years after renal failure onset. Total Medicare enrollment for ESRD quadrupled between the years 1974 and 1981.
Figures
References
-
- Aday LA, Andersen R, Fleming CV. Health Care in the US, Equitable for Whom? Beverly Hills: Sage Publications; 1980.
-
- Andersen R. Health service distribution and equity. In: Andersen R, et al., editors. Equity in Health Services: Empirical Analyses in Social Policy. Cambridge, Massachusetts: Ballinger Publishing Company; 1980.
-
- Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. Journal of Chronic Diseases. 1958;8:699–712. - PubMed
-
- Dobson A, Ruther M. Health Care Financing Review. Washington: U.S. Government Printing Office; Winter. 1981. Equal treatment and unequal benefits: a re-examination of the use of Medicare services by race, 1967-1976. Office of Research, Demonstrations, and Statistics, Health Care Financing Administration. HCFA Pub. No. 03090. - PMC - PubMed
-
- Esterling RE. Racial factors in the incidence and causation of end-stage renal disease. Transactions of the American Society for Artificial Internal Organs. 1977;(23):28–32. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical